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Abstract
Yersinia ruckeri causes yersiniosis in rainbow trout (Oncorhynchus mykiss). Yersini-
osis is the main causes of high mortalities and severe economic losses in freshwater and 
marine aquaculture. To treat and prevent yersiniosis, antibiotics and inactive vaccines 
have been used. However, use of antibiotics can cause antibiotic resistance in bacteria, 
while inactive vaccines do not provide prolonged protection against bacterial fish dis-
eases. Formation of antibiotic resistance in bacteria against antibiotics, and chemical 
contamination of the environment are some of the undesirable outcomes. For these rea-
sons, prevention of fish diseases using vaccination strategies is important for ensuring 
the profitability and sustainability of aquaculture production. 
The objective of this research is to develop live attenuated vaccines against yers-
iniosis. To reach this aim, aroA and aroC genes of Y. ruckeri have been mutated and 
virulence and efficacy of these mutants are characterized. Our main hypothesis is that 
Y. ruckeri with mutations in their aromatic amino acid biosynthesis network (aro) will 
lose their ability to cause infections in fish and these will be used as live vaccines. To 
accomplish the aim of this research, 5’ and 3’ regions of Y. ruckeri aroA (5-enolpyru-
vylshikimate-3-phosphate syntheses) and aroC (2, 3-dihydroxybenzoic acid) genes are 
amplified and DNA fragments mutated by overlap extension PCR will be cloned into 
a suicide plasmid (pDS132). This plasmid will be transferred to Y. ruckeri for replac-
ing wild type genes with mutated aroA and aroC genes via homologous recombina-
tion. Successful completion of this phase is expected to yield live attenuated vaccine 
candidates. It is expected that these live attenuated vaccines will provide resistance 
against the wild type Y. ruckeri infections in trout, and thus, prevent onset and progress 
166 V INTERNATIONAL CONFERENCE “AQUACULTURE & FISHERY” - CONFERENCE PROCEEDINGS
of diseases. Successful completion of this study is expected to prevent fish losses due 
to Y. ruckeri infections and increase the profitability of aquaculture. Contend with fish 
diseases using traditional methods is generally ineffective and expensive. 
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